A Pseudovirus‐Based Method for the Simultaneous Quantitation of Neutralization Antibodies Against All Three Poliovirus Serotypes
Authors:
Open Access
Abstract
Poliovirus is characterized by three antigenically distinct serotypes that do not elicit cross‐neutralizing antibodies. In the final stages of poliovirus eradication, the gold‐standard conventional neutralization test (cNT) for detecting serum neutralizing antibodies (NAbs) is highly restricted due to biosafety concerns. To address this, we developed a high‐throughput, tri‐color pseudovirus‐based neutralization assay (PBNA) for the simultaneous quantification of NAbs against all three poliovirus serotypes. We generated pseudoviruses by co‐transfecting cells with P1 plasmids, a replication plasmid, and a T7 RNA polymerase plasmid. By optimizing P1 expression, sensitive cell selection (HEK 293T), and plasmid transfection ratios (3:3:1 for P1, replicon, and T7 plasmids), we produced high‐titer pseudoviruses (>29‐fold increase in titers). Based on high‐titer pseudovirus encoding distinct fluorophores (E2, eGFP, and RFP), the PBNA was established, which was optimized for a 12 h incubation period, 4 × 10⁴ cells per well, and 1500 TCID 50 /mL of pseudovirus. It demonstrated high sensitivity, strong serotype specificity, and excellent reproducibility. Furthermore, the PBNA and cNT exhibited excellent congruency ( r > 0.88, all serotypes). The tri‐color PBNA provides a safe, rapid, and alternative to the cNT, making it an invaluable tool for large‐scale serosurveillance, novel vaccine evaluation, and fundamental virological investigations in the post‐eradication era.Keywords
This publication has 33 references indexed in Scilit:
- Development of a fast ELISA for quantifying polio D-antigen in in-process samplesBiologicals, 2012
- Boosting Heterosubtypic Neutralization Antibodies in Recipients of 2009 Pandemic H1N1 Influenza VaccineClinical Infectious Diseases, 2011
- Development of a Poliovirus Neutralization Test with Poliovirus Pseudovirus for Measurement of Neutralizing Antibody Titer in Human SerumClinical and Vaccine Immunology, 2011
- A guide to choosing fluorescent proteinsNature Methods, 2005
- ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccinesExpert Review of Vaccines, 2005
- Poliovirus, Pathogenesis of Poliomyelitis, and Apoptosis2005
- Antibody Responses to Antigenic Sites 1 and 3 of Serotype 3 Poliovirus after Vaccination with Oral Live Attenuated or Inactivated Poliovirus Vaccine and after Natural ExposureClinical and Diagnostic Laboratory Immunology, 2000
- Three-Dimensional Structure of Poliovirus at 2.9 Å ResolutionScience, 1985
- Primary structure, gene organization and polypeptide expression of poliovirus RNANature, 1981
- Polyadenylic Acid at the 3′-Terminus of Poliovirus RNAProceedings of the National Academy of Sciences, 1972